Navigation
Home coronavirus covid-19 vaccine AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness

AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness

AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
September 09, 2020 Excelsio Media
Share To:
AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Share
Tags coronavirus covid-19 vaccine

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

View Profile
coronavirus covid-19 vaccine

Post A Comment:

0 comments:

Leave a comment. Thanks!

Subscribe to: Post Comments (Atom)